CPIC 2026 | Protheragen Session: Global Biomedical Cross-Border Transactions
Jun 25,2026
Jointly explore sustainable and high-quality ways to expand globally.
Entering the 3.0 era of self exemption, Chinese pharmaceutical companies sit at the table
Jun 25,2026
AbbVie invests $10.9 billion in ultra long term investments
2026: Recovery, Breakthrough, and Gaming of Universal CAR-T
Jun 24,2026
Technical value is repriced by clinical data
Agenda Released! North America-China Innovative Drug Industry Collaboration Special Session
Jun 22,2026
Looking forward to exploring the North American pathway for Chinese innovative drugs going global with you.
CPIC 2026 | "Lu Lu" Debuts: The Spirit of the Eastern Unicorn, Empowering Innovation
Jun 19,2026
Injected a unique Eastern cultural blessing into CPIC 2026